Article info
Basic and translational research
Extended report
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome
- Correspondence to Professor Jürg A Schifferli, Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, Basel CH-4031, Switzerland; j.schifferli{at}unibas.ch
Citation
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome
Publication history
- Received January 26, 2015
- Revised June 24, 2015
- Accepted July 14, 2015
- First published August 5, 2015.
Online issue publication
May 10, 2016
Article Versions
- Previous version (5 August 2015).
- Previous version (1 September 2015).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/